Wegovy heart health approval won’t mean broad insurance coverage yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in …
Eli Lilly and Co
Wegovy heart health approval won’t mean broad insurance coverage yet
Victoria Klesty | Reuters In the U.S., Wegovy is no longer just for weight loss. The blockbuster drug — one of a handful of weight loss treatments to skyrocket in …
Here’s your chance to own this healthcare stock
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. U.S. stocks declined on Friday …
FDA approves NASH liver disease drug from Madrigal Pharmaceuticals
In this photo illustration, the Madrigal Pharmaceuticals logo is displayed on a smartphone screen. Rafael Henrique | SOPA Images | Lightrocket | Getty Images The Food and Drug Administration on …
WeightWatchers CEO just sent a memo to employees as stock crashes
Sima Sistani, CEO, WW International, August 16, 2023. Scott Mlyn | CNBC WeightWatchers CEO Sima Sistani has sent an internal memo to employees attempting to reassure them that the financial …
Weight loss ETFs may sit out obesity drug mania, experts say
There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week …
Eli Lilly taps Amazon Pharmacy to help deliver Zepbound, other drugs
Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021. Smith Collection | Gado | Getty Images Eli Lilly on Wednesday said Amazon …
Top 10 things to watch in the market Monday, including 5 portfolio stocks
My top 10 things to watch Monday, March 11 The S & P 500 and Nasdaq are looking lower early Monday. The decline follows a volatile session Friday when the …
Eli Lilly hits another Alzheimer’s hurdle. But obesity, diabetes GLP-1s strong
Eli Lilly ‘s experimental Alzheimer’s treatment hit another hurdle with U.S. drug regulators. It pushed out the timeline for potential approval but did not rattle our investment thesis in the …
Novo Nordisk’s Wegovy wins FDA approval for heart health benefits
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The Food and Drug Administration approved …